Will Rescheduling Cannabis Open the Industry to Increased Financing, Real Estate and Banking Opportunities?

Jack Fersko Greenbaum, Rowe, Smith & Davis LLP What You Need to Know Following the Department of Justice’s proposal to reschedule cannabis as a Schedule III controlled substance, the cannabis industry awaits a final outcome following a period of public comment. Although rescheduling would result in significant tax benefits to industry members, the manufacturing, distribution […]